Navigation Links
Compound in Biological Technology

Sigma-Aldrich Acquires ChemNavigator, Inc., to Provide Researchers With Industry-Leading Chemical Compound Selection and Procurement Services

... for design, selection and procurement of chemical compound libraries. The acquisition links ChemNavigator's ... ) core strengths in chemical compound management, procurement and global distribution ... with the complete chemical discovery offer, from compound selection to delivery of custom packaged chemical ...

InterMune Reports Second Quarter 2009 Financial Results and Business Highlights

... HCV-infected patients. Ritonavir is an antiviral compound commonly used at low doses to enhance or "boost" ... showed marked improvement. Clearance of the compound was dramatically reduced, resulting in ... with IPF (CAPACITY) has been completed and the compound is currently in the pre-registration stage. The ...

R-Tech Ueno Notifies R&D Items

... active fatty acid derivative that is a new compound developed by R-Tech Ueno and is being developed ... and neurological diseases) This compound newly developed by R-Tech Ueno demonstrates an ... VAP-1* inhibition. We intend to develop this compound as a drug indicated for atopic dermatitis, ...

New drugs faster from natural compounds: A UC San Diego breakthrough

... patenting process, however, uncovered that compound 879 had already been described as an antibiotic ... look like if a mass spectrometer had blown the compound part. "Natural products have a long history ... that enable researchers to both characterize the compound they have isolated and check to see if it, or ...

Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial

... about the potential of the investigational compound prasugrel (CS-747, LY640315) and reflects Daiichi ... beliefs. However, as with any pharmaceutical compound under development, there are substantial risks ... regulatory review. There is no guarantee that the compound will receive anticipated regulatory approvals, ...

China Sky One Medical, Inc. Signs Agreement with Taiwan Golden Biotechnology Corp. on Development of New Anti-Cancer Drug

... medicine. Antroquinonol is a kind of compound extracted from Antrodia Cinnamomea Chang & ... the United Kingdom and in the United States the compound has been approved by the U.S. FDA to enter into ... future, especially since it is rare to find a compound that can fight cancer without any side effects," ...

Onyx Pharmaceuticals Files Complaint Against Bayer Corporation

... Asserts Rights to Phase 2 Anti-Cancer compound Discovered During Joint Research ... asserting its rights to a Phase 2 anti-cancer compound discovered during joint research between Onyx and ... fluoro-sorafenib is a jointly-owned collaboration compound under the Bayer/Onyx collaboration agreement, ...

HUYA Bioscience Announces Strategic Alliance With Abbott on Drug and Biomarker Development Candidates From China

... a continuous source of compounds, unlike a single compound strategy. Once a compound is licensed, the ongoing exchange of expertise ... four strategic offices in China, a broad Chinese compound portfolio, and a significant number of exclusive ...

INFORM-1 Clinical Trial Amended to Further Explore Promising Direct Antiviral Regimen in HCV Patients

... ITMN-191 (R7227), an HCV protease inhibitor compound to be used in combination with PEGASYS(R) ... with IPF (CAPACITY) has been completed and the compound is currently in the pre-registration stage. The ... portfolio includes the HCV protease inhibitor compound ITMN-191 (referred to as R7227 at Roche) expected ...

AEterna Zentaris Presents Two Posters on its PI3K Inhibitor Compound, AEZS-126, at AACR Annual Meeting

... and In Vivo Data Show AEZS-126 as Promising Oral compound for Future Clinical Development in Cancer ... presented two posters on AEZS-126, a promising compound for clinical intervention of the PI3K/ Akt ... These data suggest that AEZS-126 is a promising compound for clinical intervention of the PI3K/Akt pathway ...

Crystal Research Associates, LLC Issues an Executive Informational Overview(R) (EIO(R)) on ACT Biotech, Inc.

... highly selective oral tyrosine kinase inhibitor compound that targets pathways associated with the ... Kinase Inhibitor (ACTB1003), an oral anticancer compound that works via several mechanisms of action: (1) ... greater anti-tumor activity in vivo . The compound may have utility in several major indications, ...

Frost & Sullivan European Drug Discovery Product Innovation Award Bestowed on Xenometrix AG

... and assay conditions. "Such in-house compound testing expertise enables the company to offer ... practical training, as well as rapid customer compound testing with all assay systems." Each year, ... screening kits designed to help to reduce test compound consumption, minimizing hands-on-time, plastic ...

TauTaTis Discovers Potent Inhibitor of Parkinson's Disease Gene Activity

... -- TauTaTis, Inc. announces that its lead compound for inhibition of tau protein pathology, the ... cause of Parkinson's Disease. TauTaTis' lead compound is a proprietary small molecule that has shown ... Based on encouraging data for our lead compound in several therapeutic areas the company will ...

Progen Concedes Shareholder Requisitioned Meeting

... yet the company elected to take the compound into Phase III trials and no partnering deal ... registration and commercialisation of a single compound to a business model that involves the development ... Recommendation A focus on a single compound development strategy is inappropriate for Progen ...

HiveMind Marketing to Enhance Search Results for Chemistry Solutions Leader ChemBridge

... in discovery chemistry services and screening compound libraries for pharma, biotech and research ... in discovery chemistry services and screening compound libraries for pharma, biotech and research ... global discovery chemistry services and screening compound library provider with an impeccable 15 year track ...

New uses for imidazolium salts in medicine and alternative energy

... sugars into 5-hydroxymethylfurfural (HMF), a key compound used in biofuel chemistry and the petroleum ... to believe that we might also be able to use this compound as a radical scavenger antioxidant to counter the ... sugars into 5-hydroxymethylfurfural (HMF), a key compound used in biofuel chemistry and the petroleum ...

NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance

... NicOx' lead investigational product and the first compound in the Cyclooxygenase-Inhibiting Nitric ... this agreement. Naproxcinod is an exciting compound and being part of its pre-launch and future ... for naproxcinod, a proprietary NCE and the first compound in the Cyclooxygenase-Inhibiting Nitric ...

China Sky One Medical, Inc. Obtains Production Rights for Nine New Drugs

... for the treatment of depression and insomnia; -- compound Paracetamol and Diphenhydramine Hydrochloride ... headaches and perennial allergic rhinitis; -- compound Tablet of Red Sage Root: for activating blood ... to dissipate blood stasis and angina; -- compound Aminopyrine Tablets: for the treatment of fever ...

Rigel Announces Third Quarter 2008 Financial Results and Clinical Update

... forward with another selective Jak3 inhibitor compound for transplant rejection. Rigel expects to select this new Jak3 inhibitor compound by the end of 2008. Rigel will proceed on its own with this compound in transplant rejection. Rigel does not plan ...

RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster

... the measurement of dose-response curves for every compound in a chemical library. The second objective is to develop a new system for compound storage in which each compound will be stored in droplets using a microfluidic ...

Memory Pharmaceuticals Completes Phase 1 Multiple Ascending Dose Study of R4996/MEM 63908

... "R4996/MEM 63908, the second compound in our nicotinic alpha-7 receptor program, has ... with Roche R4996/MEM 63908 is the second compound being developed under the Company's Nicotinic ... for conducting Phase 1 clinical trials of the compound and Roche is responsible for later ...

Retrospective Analysis of Phase 3 Data Suggest Wyeth's Investigational Compound Bazedoxifene/Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms

... placebo. BZA/CE is an investigational compound being studied by Wyeth Pharmaceuticals, a ... postmenopausal osteoporosis. Wyeth describes this compound as a tissue selective estrogen complex (TSEC). ... 3 study, treatment with Wyeth's investigational compound bazedoxifene (BZA) alone did not appear to ...

Kiwa Bio-Tech 2nd Quarter Revenues Increase 61.7% to $3 Million, Six Month Revenues Top $5.2 Million

... Fertilizer Group agreed to develop new compound bio-fertilizers to address the growing Chinese market for compound bio-fertilizers as an alternative to chemical ... chemical fertilizers, complex fertilizers and compound fertilizers. Based on applicable tax laws in ...

Neurocrine Biosciences Reports Second Quarter 2008 Results

... forward to meet our goal of advancing a novel compound into the clinic each year. All of this is taking ... to meet the Company-wide goal of bringing one new compound into development each year. GnRH Antagonists ... have arisen out of the GSK collaboration. The compound (876008) is in a Phase II "proof of ...

Organizational Changes at Silence Therapeutics

... clinical trials for our lead internal development compound Atu027. I intend to commence ... to Pfizer via Quark's license to them of the compound RTP-801i-14 for the treatment of age-related ... (AMD) and a number of other indications. This compound entered the clinic in early 2007. ...

Study reveals principles behind stability and electronic properties of gold nanoclusters

... principles underlying the 102-atom gold compound and others like it. The team conducted ... with the filled electron shell, the gold-thiolate compound also had a major energy gap to unoccupied states. ... molecular orbital states for the 102-atom compound was significant 0.5 electron volts. Metals ...

ImQuest Awarded SBIR Grant to Define the Mechanism of Action of Their Lead Anti-HIV Therapeutic Compound IQP-0410

... target cells, extends the range of action of the compound to HIV-2 and results in enhanced levels of ... hopes to more completely understand how this compound inhibits HIV replication, initiate our ... results have been highly encouraging that the compound will present a new highly potent and less toxic ...

Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration

... XL880 and will be able to choose one additional compound from among XL184, XL281, XL228, XL820, and ... efforts against any collaboration target or compound that does not infringe upon the intellectual ... facility. Additionally, if GSK selects a second compound for further development, Exelixis will ...

FDA Approves Quark IND for DGFi, an siRNA Therapeutic Based on Silence Therapeutics' Unique Proprietary Chemistry

... Pfizer through Quark's license to Pfizer of the compound RTP-801i-14, for the treatment of age-related ... (AMD), and a number of other indications. This compound entered the clinic in early 2007. ... for its proprietary compound, AKIi-5. This Quark compound is in a Phase I human clinical study for ...

Kiwa Bio-Tech Receives Authorization From the Ministry of Commerce of the People's Republic of China to Wholesale Other Fertilizer Manufacturers Products

... chemical fertilizers, complex fertilizers and compound fertilizers. Based on applicable tax laws in ... By the end of 2007, its production capacity of compound fertilizer has reached 2 million tons. In the same year, production and sales of compound fertilizer hit 1.5 million tons, with sales ...

Ikaria Introduces Dr. Michael Cooreman as Vice President of Translational Medicine

... early as possible the indications for which a new compound will most likely show therapeutic benefit, based on the known interaction of the compound in disease pathways, in addition to confirmation of safety and efficacy of that compound in animal studies. Once likely indications are ...

Novel compound may treat acute diarrhea

... Science Center at Houston have discovered a novel compound that might lead to an inexpensive, easy-to-take ... Sciences of the United States of America. The compound - a pyridopyrimidine derivative - targets acute ... diarrhea. During pre-clinical tests, the compound was associated with a significant reduction in ...

Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference

... has recently submitted an NDA to the FDA, is a compound for the treatment of schizophrenia. Vanda's second product candidate, tasimelteon (VEC-162), is a compound for the treatment of sleep and mood disorders, ... Vanda's third product candidate, VSF-173, is a compound for the treatment of excessive sleepiness in ...

NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect

... novel, radicicol-based Hsp90 inhibitors in its compound series. NXD30001 demonstrated efficacy in ... in Phase 2 clinical trials for cancer. The compound series appears to bind Hsp90 in a different mode ... via intraperitoneal (i.p.) dosing and that the compound accumulates in tumors at above ...

Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery

... Pfizer through Quark's license to Pfizer of the compound RTP-801i-14 for the treatment of Age-related ... (AMD) and a number of other indications. This compound entered the clinic in early 2007. Silence ... to the AtuRNAi structure for its proprietary compound AKIi-5. This compound is in a Phase I human ...

Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs

... with Roche. MEM 3454, the lead compound in the Company's nicotinic alpha-7 receptor ... is currently evaluating the compound as a treatment for cognitive impairment ... a favorable safety profile for the compound overall and particularly with respect to ...

Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results

... diabetes and cancer. Keryx's lead compound under development is Sulonex(TM) (sulodexide) ... to as KRX-101, a first-in-class, oral heparinoid compound for the treatment of diabetic nephropathy, a ... is developing Zerenex(TM), an oral, iron- based compound that has the capacity to bind phosphate and form ...

Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST

... diabetes and cancer. Keryx's lead compound under development is Sulonex(TM) (sulodexide) ... to as KRX-101, a first-in-class, oral heparinoid compound for the treatment of diabetic nephropathy, a ... is developing Zerenex(TM), an oral, iron- based compound that has the capacity to bind phosphate and form ...

Keryx Biopharmaceuticals Announces Additions to Management Team

... diabetes and cancer. Keryx's lead compound under development is Sulonex(TM) (sulodexide oral ... to as KRX-101, a first-in-class, oral heparinoid compound for the treatment of diabetic nephropathy, a ... is developing Zerenex(TM), an oral, iron- based compound that has the capacity to bind phosphate and form ...

InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance

... study of ITMN-191, our first experience with the compound in patients chronically infected with the ... of 2008 to gain FDA approval to study the compound in the United States. Conference Call and ... portfolio includes the HCV protease inhibitor compound ITMN-191 (referred to as R7227 within the ...
Other Contents
(Date:7/11/2014)... German . ... refraction of X-rays through a specimen instead of attenuation ... are often of much higher quality than those based ... Franz Pfeiffer are particularly interested in developing new approaches ... phase-contrast imaging. One main goal is to make this ...
(Date:7/11/2014)... July 3, 2014, Shenzhen, China Researchers from Salk ... for the first time evaluated the safety and ... and successfully developed a new method, TALEN-HDAdV, which ... pluripotent stem cell (hiPSC). This study published online ... important theoretical foundation for stem cell-based gene therapy. ...
(Date:7/11/2014)... July 11, 2014 Researchers have pioneered a ... The new technology, called Virtual Finger, allows scientists ... like neurons and synapses using the flat surface ... makes 3D imaging studies orders of magnitude more ... unprecedented level across many areas of experimental biology. ...
Breaking Biology News(10 mins):New simple setup for X-ray phase contrast 2A new genome editing method brings the possibility of gene therapies closer to reality 2Virtual finger enables scientists to navigate and analyze complex 3D images 2
(Date:7/14/2014)... 14, 2014 NATURALLY, DANNY SEO, a ... Publications, debuts with a Fall issue that hits newsstands ... at living the healthy, natural and good for you ... from food, beauty, travel, home, and entertaining all through ... living. , “Instead of gimmicky weight loss tips and ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 According to the ... is a helpful guide that features a series of new ... in its review that this book can help readers understand ... of high blood pressure, and effective methods to control ... are reviewed now by Vkool, was penned by Ken Burge, ...
(Date:7/14/2014)... Vaginal Mesh lawsuit claims continue ... pelvic mesh manufacturers in the U.S. District Court, Southern ... The federal complaints are pending against pelvic mesh manufacturers ... Systems (MDL No. 2325), and C.R. Bard, Inc., (MDL ... Vaginal Mesh lawsuit claims pending, according to statistics from ...
(Date:7/14/2014)... Grove, IL (PRWEB) July 14, 2014 ... online marketing company for mental health professionals, announced ... Counselors Association of North Carolina (LPCANC). This ... their online marketing solutions to LPCANC members, adding ... past 7 years, we have been dedicated to ...
(Date:7/14/2014)... Townsend Security, a leading authority in ... i (AS/400, iSeries) Two Factor Authentication Partner Program ... evolve and make passwords ineffective for system and ... applications and implement two factor authentication (2FA). Townsend ... ISVs on the IBM i platform to rapidly ...
Breaking Medicine News(10 mins):Health News:Harris Publications and Danny Seo Launch NATURALLY, DANNY SEO Magazine 2Health News:Harris Publications and Danny Seo Launch NATURALLY, DANNY SEO Magazine 3Health News:Harris Publications and Danny Seo Launch NATURALLY, DANNY SEO Magazine 4Health News:Harris Publications and Danny Seo Launch NATURALLY, DANNY SEO Magazine 5Health News:Harris Publications and Danny Seo Launch NATURALLY, DANNY SEO Magazine 6Health News:Blood Pressure Solution Book Review Exposes Ken Burge's Hypertension Treatment Guide – Vkool.com 2Health News:Blood Pressure Solution Book Review Exposes Ken Burge's Hypertension Treatment Guide – Vkool.com 3Health News:Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers 2Health News:Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers 3Health News:Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers 4Health News:Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers 5Health News:TherapySites Partners With the Licensed Professional Counselors Association of North Carolina to Make Online Marketing Available to All Therapists 2Health News:IBM i ISVs Can Now Easily Integrate Mobile-Based Two Factor Authentication to Increase Security of Solutions 2Health News:IBM i ISVs Can Now Easily Integrate Mobile-Based Two Factor Authentication to Increase Security of Solutions 3
Other TagsOther Tags